Hong Kong, April 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM), a leading Biotechnology company, today announced that it has received a notification from the Nasdaq Stock Market LLC ...

The "Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025" report has been added to ResearchAndMarkets.com's offering.Asset Purchase Deals in Pharmaceuticals and Biotechnology provides ...

CellVoyant leverages AI and live-cell imaging to predict cellular behavior, transforming cell therapy development and making ...

Colossal’s woolly mammoth patent application, with its descriptions of modified cells and animals, represents “the current ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

About GRI Bio, Inc. GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio’s therapies are ...

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the addition of a new membrane protein workflow to ...

Chime Biologics, a leading global CDMO that enables its partners' success in biologics, is pleased to announce a strategic ...

Mezofy, an oral film-type medication for treating schizophrenia developed by CMG Pharmaceutical, received approval from the U ...

Explore the latest changes in drug pricing as Trump aims to revamp Medicare negotiations for prescription drugs.